Input 2021.03.01 12:19
“Fully agree that it has a patient protection effect”
Distribution of first volume next month, supply of 100 million times in the first half
ACIP, CDC’s external expert advisory body, held a meeting that day and voted to recommend J&J vaccination for those over 18 years of age and unanimously decided on the recommendation. Accordingly, CDC Director Rochelle Wallensky immediately signed the advisory committee recommendations.
“The J&J vaccine has been shown to be effective in protecting patients from hospitalization and death following Corona 19 infection,” said Wallensky, making a statement that day. “I fully agree with the advisory committee’s recommendations.”
This is a follow-up to the U.S. Food and Drug Administration (FDA) approving the emergency use of the J&J vaccine the day before. With this approval, the U.S. will secure a third vaccine that can be vaccinated after the domestic pharmaceutical company Modena and Pfizer and Bioentech vaccines.
Unlike Pfizer, Moder, and vaccines, which require two doses of the J&J vaccine, one dose provides an immune effect. In addition, since it is not necessary to freeze storage, restrictions on distribution and storage of vaccines are reduced, and the time required to schedule and schedule vaccinations is reduced.
According to the Associated Press, J&J vaccine will begin shipping on this day. The first volume will be distributed from the 2nd of next month, two days later. The federal government plans to supply 20 million doses to the US by the end of next month and 100 million doses in the first half of the year.
“The J&J vaccine makes it possible to get the vaccine as quickly as possible and fairly to as many people as possible,” said Wallensky. “It is disposable and easy to transport and store, which will speed up vaccination.”